# Study of Tirzepatide for Recovery and Alcohol Use Management

> **NCT06727331** · PHASE2 · RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Alcohol Use Disorder (AUD)

## Interventions

- **DRUG:** Tirzepatide
- **OTHER:** Saline Placebo

## Key facts

- **NCT ID:** NCT06727331
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2026-05
- **Final completion:** 2026-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06727331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06727331, "Study of Tirzepatide for Recovery and Alcohol Use Management". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06727331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*